$250 | Single User
$500 | Site License
$750 | Enterprise License

North China Pharmaceutical Co., Ltd. (600812) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
[Lowest Price Guaranteed: $250]

Published by Global Data: 11 May 2016 | 12557 | In Stock
Related Topics: Business , Equity , Financial , Healthcare , Pharmaceuticals

Introduction

Summary

North China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a pharmaceutical company that develops, produces and sells novel drugs and pharmaceutical related products. The company’s products include benproperine phosphate, vitamin EC particles, bismuth potassium citrate, compound paracetamol, vitamin B1 particles benorilate, children paracetamol huang min particles, relying erythromycin particles, erythromycin particles, pediatric dual sulfur particles, and pediatric sulfamethoxazole particles. It offers products in the dosage forms of granules, capsules, and tablets. The company markets its products in the US, the Democratic Republic of Congo, India, Dubai and Europe. NCPC is headquartered in Shijiazhuang, China.

North China Pharmaceutical Co., Ltd. (600812) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for North China Pharmaceutical Co., Ltd. (600812) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 4

    North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

    North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

    North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 8

    North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deal Details 9

    Equity Offering 9

    North China Pharma Receives Approval From China Securities Regulatory Commission For Private Placement Of Shares For US3.4 Million 9

    North China Pharma Completes Private Placement Of Shares For US1 Million 10

    North China Pharma Announces Private Placement Of Common Stock For US6 Million 11

    Debt Offering 13

    North China Pharmaceutical Plans to Raise USD108.2 Million in Public Offering of Bonds Due 2021 13

    North China Pharma Announces Public Offering Of Notes For US Million 14

    Acquisition 15

    North China Pharma To Acquire Remaining 50% Stake In Pharmaceutical Company For US.2 Million 15

    Jointown Pharma To Acquire 49% Stake In NCPC International For US.7 Million 16

    North China Pharmaceutical Co., Ltd. - Key Competitors 17

    Locations And Subsidiaries 18

    Head Office 18

    Appendix 19

    Methodology 19

    About GlobalData 19

    Contact Us 19

    Disclaimer 19

List Of Tables
in North China Pharmaceutical Co., Ltd. (600812) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Tables

North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Key Facts, 2014 1

North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 1

North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 8

North China Pharma Receives Approval From China Securities Regulatory Commission For Private Placement Of Shares For US3.4 Million 9

North China Pharma Completes Private Placement Of Shares For US1 Million 10

North China Pharma Announces Private Placement Of Common Stock For US6 Million 11

North China Pharmaceutical Plans to Raise USD108.2 Million in Public Offering of Bonds Due 2021 13

North China Pharma Announces Public Offering Of Notes For US Million 14

North China Pharma To Acquire Remaining 50% Stake In Pharmaceutical Company For US.2 Million 15

Jointown Pharma To Acquire 49% Stake In NCPC International For US.7 Million 16

North China Pharmaceutical Co., Ltd., Key Competitors 17

List Of Figures, Charts and Diagrams
in North China Pharmaceutical Co., Ltd. (600812) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Figures

North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1

North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1

North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1

North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6

North China Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Additional Details

Publisher

Global Data

Publisher Information

Reference

12557 | GDPH207627D

Number of Pages

19

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic SWOT Analysis Review
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC) a subsidiary of North China Pharmaceutical Group ...
11 Jul 2016 by Global Data USD $300 More Info
University of North Carolina - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryUniversity of North Carolina (UNC) is an educational service provider that offers academic co...
13 May 2016 by Global Data USD $250 More Info
North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNorth China Pharmaceutical Group Corp. (NCPC) is a pharmaceutical company that manufactures a...
10 May 2016 by Global Data USD $250 More Info
North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic SWOT Analysis Review
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a ...
15 Apr 2016 by Global Data USD $300 More Info
University of North Carolina - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryUniversity of North Carolina (UNC) is an educational service provider that offers academic co...
17 Mar 2016 by Global Data USD $250 More Info
North China Pharmaceutical Co., Ltd. (600812) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a ...
15 Mar 2016 by Global Data USD $250 More Info
North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNorth China Pharmaceutical Group Corp. (NCPC) is a pharmaceutical company that manufactures a...
15 Mar 2016 by Global Data USD $250 More Info
North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic SWOT Analysis Review
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a ...
09 Jan 2016 by Global Data USD $300 More Info
North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic SWOT Analysis Review
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a ...
08 Nov 2015 by Global Data USD $300 More Info
North America Clinical Chemistry Market Outlook to 2021
North America Clinical Chemistry Market Outlook to 2021SummaryGlobalData’s new report, "North Americ...
04 Sep 2015 by Global Data USD $3,000 More Info

This report is published by Global Data

Download Free Report Summary PDF

North China Pharmaceutical Co., Ltd. (600812) - Pharmaceuticals & Healthcare - Deals and Alliances Profile | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...